chrisvoncsefalvay/vaers-outcomes huggingface dataset:
urticarial rash over most of body onset about 24 hrs p/immun as few hives on face; following day had diffuse urticaria;
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with the second dose of GARDASIL. A few weeks after receiving the second dose, the patient had broken out in genital warts. The patient had come into the office about the experience and the physician referred her to an Obstetrician/Gynecologist. The physician did not know at the time when the patient received the first dose because she received it in Texas. At the time of this report, the outcome was unknown. Additional information has been requested.
COULD NOT MOVE; SORENESS; EXHAUSTION / TIRED; SORE THROAT; RUNNY NOSE; CONGESTION; This spontaneous report received from a patient concerned a 29 year old male. The patient's height, and weight were not reported.  The patient's past medical history included anaphylaxis reaction, leg injury, blood clot in leg, flu, sickness, and viral infection, and concurrent conditions included peanut allergy, alcohol use, and smoker, and other pre-existing medical conditions included was working a lot to the point that immune system was shut as no chance to recover, at this time was using claritin and zyrtec and developed tolerance to them and that is why not using any medication now he also stated using dayqail and nightqail at that time and was told to quit running.  The patient was previously treated with loratadine for flu, and cetirizine hydrochloride for flu.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On SEP-2017, Laboratory data included: X-ray (NR: not provided) blood clot in the leg. On 08-JUL-2021, the subject experienced runny nose. On 08-JUL-2021, the subject experienced congestion. On 19-JUL-2021, the subject experienced sore throat. On an unspecified date, the subject experienced could not move, soreness, and exhaustion / tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from could not move, soreness, runny nose, and exhaustion / tired, and had not recovered from congestion, and sore throat. This report was non-serious.
Flu-like symptoms (2nd dose); Bad headache (2nd dose); Body aches (2nd dose); Fever (2nd dose); This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms (2nd dose)), HEADACHE (Bad headache (2nd dose)), MYALGIA (Body aches (2nd dose)) and PYREXIA (Fever (2nd dose)) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthmatic.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms (2nd dose)), HEADACHE (Bad headache (2nd dose)), MYALGIA (Body aches (2nd dose)) and PYREXIA (Fever (2nd dose)). On 16-Mar-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms (2nd dose)), HEADACHE (Bad headache (2nd dose)), MYALGIA (Body aches (2nd dose)) and PYREXIA (Fever (2nd dose)) had resolved.            No Concomitant medication was reported.  No Treatment medications were reported   This case was linked to MOD-2021-307233 (Patient Link).
local reaction; long read area; which was also warm.; This case was reported by a pharmacist via call center representative and described the occurrence of local reaction in a adult patient who received Herpes zoster (Shingrix) (batch number ZR979, expiry date 28th March 2022) for prophylaxis.   On 17th August 2020, the patient received the 1st dose of Shingrix. In August 2020, less than 2 weeks after receiving Shingrix, the patient experienced local reaction, erythema and skin warm. On an unknown date, the outcome of the local reaction, erythema and skin warm were unknown.   It was unknown if the reporter considered the local reaction, erythema and skin warm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The Shingrix applied ten days ago and patient had a local reaction with a long read area which was also warm. The reporter consented to follow up. No patient's identifiers were provided.  Requested to follow up.
Patient said that he developed fever the next day and lump developed under the left arm pit. Advised patient to have provider further evaluate situation.
Patient had fever after booster dose of COVID-19 vaccine presented to ER with seizures, admitted for observation
Pfizer 3/3/21, 3/31/21, 11/12/21. Positive on 8/5/22
Mild itchiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Mild itchiness at injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PRURITUS (Mild itchiness at injection site). At the time of the report, INJECTION SITE PRURITUS (Mild itchiness at injection site) outcome was unknown.            No concomitant medications were provided. No treatment medication was provided.   Reporter did not allow further contact
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 30-JUL-2014 and on  02-FEB-2015 the patient was vaccinated with GARDASIL injection (lot number, expiration date, route and anatomical location of administration were reported). On 11-SEP-2015, the patient was vaccinated with the partial dose of GARDASIL 9 injection, (lot number, expiration date, route and anatomical location of administration were not reported). No adverse symptoms were reported and no product quality complaint was involved. Additional information has been requested.
The patient fainted about 20 seconds after I gave her the vaccine.  I lowered her to the floor and  was going to lay her on her side when she regained consciousness.  She then felt nauseous and stayed on the floor for about 15 minutes. She never vomited. She started drinking her beverage  and felt better in about 25 minutes.  She communicated that she did not need further medical attention and I agreed.
Information has been received from a 59-year-old male (also reported as 34-year-old) with glaucoma in both eyes, hypertension, prostatitis, a history of chickenpox, no known allergies and no history of immunosuppressive therapy or immune compromise who on 10-DEC-2007 splashed a few drops of Zostavax (Oka/Merck) (lot # "1141U") into his left eye while administering the vaccine to a 75-year-old woman (she jumped during administration and it squirted into his left eye).  The left eye became red and irritated after flushing with saline.  Concomitant therapy included hydrochlorothiazide, aspirin, metoprolol, DOXASIN and TRAVATAN.  The patient sought unspecified medical attention.  No diagnostic labs were performed.  The patient stated that "his eyes were irritated for a few days but it was probably due to all the water he flushed it out with".  On an unspecified date the patient recovered.  A product quality complaint was not involved.  Additional information is not expected.
Presented to the emergency department from urgent care because he was hypoxic to 89%  on room air, 6 days of symptoms previously with a cough, headache, myalgias. Positive covid test today, Wife was covid positive. 2L O2 via nasal cannula, Decadron, pulmonary consultation
The same night that I received my vaccine, I initially was experiencing some light chest pain and felt a bit off. Not particularly sick but unwell. Throughout that night, I had a lot of reflux happening as well. I woke up the next morning and started my day regularly but as the day went on, I developed fever, chills, arm pain, left side chest pain. Around 2PM that day, I drank some water and tried to sleep because I thought I was dehydrated due to some kidney pain I was feeling as well. As the day went on, I was just feeling worse and it got to the point that when I would do anything like laugh, I was experiencing chest pain. I did take some Ibuprofen and Acetaminophen to treat the pain. When I woke up, it felt a bit better, but it got worse again as the day went on. I went to a local urgent care who couldn't treat me there since it was possibly a heart issue. I was seen at another location where they did an EKG that showed normal results. They stated that it may be just some muscle issues in the chest, and they prescribed some muscle relaxers which I have not taken due to the side effects. Today and yesterday, I was still feeling chest pain, but it has subsided quite a bit. The fatigue is still there, but also not as bad. I also experienced some vertigo, diarrhea, and nausea in the first few days following my vaccine.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Pregnant.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 07-Oct-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) to be not related.    No concomitant information was reported. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: No specific follow-up information recorded.
Patient broke out with a papular rash 2 days after receiving varicella vaccine. Mom stated this after child received MMR on 1/30/07
Myalgia, Mild soreness in arm lasting + days, fatigue x4days Narrative:
Fever 101.6, chills, muscle pain, weakness  started the morning after vaccine was given. Later that day, abdominal pain(bloating, gas) nausea.
Information has been received from a physician concerning a female who on 23-APR-2008 was vaccinated with GARDASIL (Lot #, dose and site not reported).  On 23-APR-2008 the patient fainted after receiving GARDASIL.  Approximately 10 minutes after fainting, the patient recovered.  No further information was provided.  Additional information has been requested.
Patient had onset of bilateral post cervical adenopathy, sore throat, faint rash on chest, and pain in joints.  The onset time is unknown but I had to enter something to go to next screen!!
This was my first vaccine--Tainted taste/fowl taste for over two weeks continuously. It has subsided but is still there a majority of the time. I got my second vaccine yesterday--hoping it does not come back full force or that it is worse than the last vaccine.
About 4 days after I received the vaccine, I developed hives. They were mostly around my arm and neck, but I was itchy all over. I treated them with OTC meds and they lasted about a month or so.
Information has been received from a physician concerning a 15 year old female who on 13-AUG-1998 was vaccinated with the first and only dose of VARIVAX (Merck) at 3 years of age. The patient had no prior medical history and was healthy. On 22-APR-2009, the patient developed a severe headache and took MOTRIN and then EXCEDRIN MIGRAINE without relief. The patient developed a rash which spread to her right flank that was painful, no fever was noted. The patient developed blurred vision and was seen in the emergency room and was admitted to the hospital. Enterovirus was suspected and a lumbar puncture was done. Polymerase chain reaction (PCR) test was done at the hospital and cerebral spinal fluid (CSF) was negative for enterovirus but positive for varicella zoster virus. The patient was diagnosed with shingles and treated with acyclovir. The physician didn't see discharge information on the ID consult so she thought the patient was still admitted. The physician expressed interest in the VZIP program and explained that they had additional CSF fluid in the lab which they would send for PCR testing. Additional information has been requested.
ON 5/13/22 AROUND 8:30AM STAFF REPORTED HAVING "HIVES" IN THE UNDERARM AREA. STAFF NURSE VIEWED RED RAISED HIVE-LIKE WELPS ON THE UNDERSIDE/UNDER ARM AREA OF BOTH ARMS. CONDITION DID NOT WARRANT AN MD VISIT. TREATED WITH HYDROCORTISONE CREAM. UPON LEAVING AT END OF SHIFT AT 2PM, STAFF DENIED ANY ITCHING AND REPORTED THE AREA HAD NOT WORSENED.  STAFF HAS QUIT.
on Monday 8/12/19 pt reported 100 degree fever, Tuesday 8/13/19 pt reported 99.3 degree fever, pt had body aches and tiredness.  on Wed 8/14/19 pt went to md for "chest congestion and fluid in ear" - she was given ABX.  on after noon of 8/14/19 pt developed a small red rash on the right side of her right check.  Raised and slightly itchy
Patient complained of redness, hardness and swelling at injection site (size of a nickel) 1 day after the vaccine. Pharmacist counseled that one of the common side effects of the vaccine is pain/redness/swelling in the arm . Pharmacist also advised her to take some pain reliever and see a doctor if the pain and swelling get worse. Patient went to the ER on Sunday 5/2/2021 as her muscle pain did not improve and hot to touch. She was told by the ER that the injection site possibly was infected and given antibiotic for a couple days. Talked to patient again on 5/5/2021, her pain and swelling at injection site since then was improved.
Information has been received from a physician concerning an 18 year old female with no pertinent medical history and with penicillin allergy who on 03-AUG-2009 was vaccinated with the first 0.5ml dose of GARDASIL (lot number not reported), on 08-OCT-2009 the patient was vaccinated with the second 0.5ml dose of GARDASIL (lot number not reported), and on 19-MAR-2010 the patient was vaccinated with the third 0.5ml dose of GARDASIL (lot number 665768/1354Y), via intramuscular. Concomitant therapy included birth control pills (unspecified). On 21-MAR-2010 the patient developed arthritic type pain on the arm opposite of injection site and spread up to her neck. A nurse reported that the patient experienced joint pain after her third dose of GARDASIL. No lab diagnostics studies were performed. The patient's experiences persisted. On 22-MAR-2010, the patient sought unspecified medication via a telephone call. Follow-up information was received from a physician. It was reported that the female (student) had no previous exposure to this or related drug and no problems were noted with the first two dose GARDASIL immunizations. On 20-MAR-2010, the patient experienced local erythema at injection site. After 2 days, on 22-MAR-2010 the patient recovered from local erythema at injection site. On 22-MAR-2010, the patient experienced arthralgias in right shoulder, wrist and elbow. After 7 days, on 28-MAR-2010, the patient recovered from arthralgias in right shoulder, wrist and elbow. No further information is available.
soreness in the injection; headache; This is a spontaneous report from a Non-contactable Nurse reported for herself. This female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunisation. The medical history and concomitant medications were not reported. The patient had the first dose of the vaccine and mentioned that she experienced the expected adverse events of soreness in the injection site and headache. She said she felt better after multiple ibuprofen (ADVIL). The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Fever of 103. Chills and severe body aches; headache; exhaustion and fatigue. I had brain fogginess - brain was disconnected from thought process. That all lasted from Wednesday-Sunday. It got a little better each day (Wednesday and Thursday were really bad.)  I took aspirin - it helped relieve the headache.
I had covid symptoms for 3 days. Now theres some kinda damage to the arm that I got the shot in cause I have very limited motion and shooting pains down my shoulder and arm at all times
12/15/99 - Pt awoke p.m. and vomited.  Temp of 103 F.  12/14/99 - red throat, culture neg. for strep, no cold sx and no fever.  At midnight, convulsions, stopped breathing, CPR.  Source of infection, unknown. Anti-seizure med given
Began feeling systemic body aches, stiffness in legs and hips, weakness in arms. Nausea and fever, chills by 6:30pm. Nausea, fever, chills subsided within 10 hours. Joint stiffness and aching in legs and hips continued for six weeks, however it was worsened by a severe, almost crippling pain through the left knee and what felt like the left calf and bone being crushed in a vice.  Doctor ordered x-rays of left leg and knee; came back inconclusive. My legs felt as though they were heavy boards and my feet were bricks. The discomfort was intense, and pain moving (especially coming down a set of stairs) was unbelievable. The discomfort seemed to run in waves ... it appeared to be improving a little after ten days or so for a day or two, then flared up for another 10 days or so. After about 5 weeks, the discomfort seems to have subsided in earnest, and has all but disappeared.
Information has been received from a physician concerning a female patient who, on an unknown date, was vaccinated with a dose of GARDASIL (lot #, dose and route not reported). The physician reported that her patient developed arm pain and knots on her arm, after receiving the GARDASIL (date unspecified). The physician reported that the patient's arm was in a sling. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. No further information is available.
HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/9/2022 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY
Information has been received from a health professional concerning a 15 years old female who was vaccinated with GARDASIL last week, approximately in July 2009. After vaccination the patient waited 15 minutes before leaving the office. She hit her head when she fell. She also experienced vomiting later that day. The patient was hospitalized that day. At the time of the report, the patient had not recovered. Additional information has been requested.
After I got my vaccine, I was fine, my arm was a little sore and the next day I had a dull headache.  But then I was ok.  However, last evening, Friday, February 19, 2021, as I stepped into the shower, I noticed that my arm was red at the injection site.  It was quite red and somewhat hard.  That is the first time I noticed it.  This morning it has faded some and not as hard.  The spot is about 3" long by 2" wide.  It does not hurt and I feel fine.  Just thought I should report it.
Approx three weeks after vaccine developed eye droop , loss of nasal fold, mouth droop, tingling and pins and needles going into lip and across the top lip into r side of face.  All this on my left side, starting at the eye with pain and pain into nose.
dermal filler under eye and cheek was administered one year prior, and 1 week after second dose of vaccine.  extreme swelling, inflammation, under eye and cheek about 3 weeks after.  painful and unsightly
This spontaneous report was received from a healthcare worker concerning unspecified patients (demographics unknown). The healthcare worker reported that doses of VAQTA (Lot # not provided) which were exposed to an unsupported temperature excursion on 08-DEC-2014, had been administered for unspecified patients on unspecified dates since 08-DEC-2014. No adverse effect had been reported. This is one of several reports received from the same source. Additional information has been requested.
20 minutes after receiving the injection, my child told me that she couldn't see and that her ears were ringing.  She was extremely pale and her pupils were fully dialated.  She passed out and was assisted by a nurse at the doctor's office.  No further treatment was administered.  My child complained of an moderate headache that evening.  All symptoms were resolved by this morning.
Bladder infection -> BACTRIM 10/17/10 5 days txt 1 BID. Within 24 hrs. - aching, headache = sick. Went out of town & got very sick. 10-25-10. Blinding headaches in back of head = flame in back of head. Lift head with both hands to lift head. Crippled in legs 10/22 = very sick. 10/23 - really sick. 10/27 called dr. Nov 5th - Dr. - ophthalmologist. 80mg prednisone daily for eyes. Fall on toilet. To put slacks on - had to lift legs with hands. Joints - really bad - after Prednisone by PM - joints improved. Giant cell arimatica = txt. Poly myalgia = txt. Went to office - 10-29 appt. Went to - eye dr. - arteritis (blinding) - 80mg Prednisone ASAP. Biopsy on temporal artery - negative. Within 7% error rate. 75mg/day Prednisone. Rheumatologist - going to see now Dr. continues to treat.
This spontaneous report as received from a healthcare worker refers to a 2 patients of unknown age and gender. Concomitant therapy pertinent medical history or drug reactions/allergies were not reported. On an unknown date the patients were vaccinated with RECOMBIVAX HB (0.5 ml, intramuscularly) that underwent a temperature excursion. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
We do not have immunization info for dose 1 New onset stroke symptoms/Stroke Alert 5.18.21 @ 1244pm following second dose of vaccine administered 5.17.2021.  MRI + acute stroke, emergent TPA administered. Currently remains inpatient on ICU level of care.
difficulty with urination; This case was reported by a consumer via call center representative and described the occurrence of urination difficulty in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced urination difficulty. On an unknown date, the outcome of the urination difficulty was not recovered/not resolved.   It was unknown if the reporter considered the urination difficulty to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingrix, the patient experianced difficulty with urination. The reporter wanted to know difficulty with urination side effect of Shingrix.